Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/positive-results-in-the-interim-analysis-of-the-clinical-trial-of-recbios-novel-adjuvanted-recombinant-shingles-vaccine-rec610-in-the-philippines-302023639.html
https://www.prnewswire.com/news-releases/jiangsu-recbio-technology-co-ltd-announced-2023-interim-results-report-and-latest-progress-301910777.html
https://www.prnewswire.com/news-releases/acceptance-of-clinical-trial-application-for-the-recbios-novel-adjuvanted-recombinant-shingles-vaccine-rec610-in-china-and-overseas-clinical-trial-progress-301886939.html
https://www.prnewswire.com/news-releases/two-component-recombinant-covid-19-vaccine-recov-granted-with-emergency-use-authorization-in-mongolia-301776938.html
https://www.prnewswire.com/news-releases/clinical-trial-approval-for-the-companys-novel-adjuvanted-recombinant-shingles-vaccine-rec610-in-the-philippines-301705875.html
https://www.prnewswire.com/news-releases/superior-results-of-the-comparative-study-of-the-companys-recombinant-two-component-covid-19-vaccine-recov-as-compared-to-international-mainstream-mrna-vaccine-301702595.html
https://www.prnewswire.com/news-releases/jiangsu-recbio-technology-co-ltd-increases-production-for-the-first-phase-of-manufacturing-facility-with-a-maximum-annual-output-of-20-million-doses-of-recombinant-hpv-9-valent-vaccine-301683614.html
https://www.fiercebiotech.com/biotech/recbio-inks-oct-clinical-phase-3-sars-trial
https://www.prnewswire.com/news-releases/recbio-announces-interim-results-for-the-fiscal-year-2022-and-company-progress-301613582.html
https://www.prnewswire.com/news-releases/completion-of-subject-enrollment-and-vaccination-for-the-comparative-study-between-recov-and-mrna-vaccines-301608999.html